M&A Deal Summary

Arsenal Capital Partners Acquires Accumen

On January 17, 2019, private equity firm Arsenal Capital Partners acquired life science company Accumen

Acquisition Highlights
  • This is Arsenal Capital Partners’ 4th transaction in the Life Science sector.
  • This is Arsenal Capital Partners’ 38th transaction in the United States.
  • This is Arsenal Capital Partners’ 4th transaction in California.

M&A Deal Summary
Date 2019-01-17
Target Accumen
Sector Life Science
Buyer(s) Arsenal Capital Partners
Deal Type Buyout (LBO, MBO, MBI)
Advisor(s) Nexus Health Capital LLC (Financial)
GreenbergTraurig (Legal)

Target

Accumen

San Diego, California, United States
website
Accumen is a healthcare performance partner providing end-to-end strategy and services to drive value and long-term sustainability for the clinical lab, outreach services, patient blood management, and imaging services. Accumen offers health system partners consulting, execution, utilization, and outreach solutions using a proven blueprint, innovative approach, and insight-driven proprietary technology. Accumen was founded in 2011 and is based in San Diego, California.

Search 193,724 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Arsenal Capital Partners

New York, New York, United States

Investor Investor Investor Investor Investor

website

Category Private Equity Firm
Founded 2000
PE ASSETS 10.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

Arsenal Capital Partners is a private equity firm focused on middle-market healthcare, specialty industrial, and financial service companies. Specifically, Arsenal looks to acquire businesses in the areas of specialty chemicals, aerospace/defense, transportation, environmental services, business services, insurance, asset management, financial technology, medical products, healthcare IT, and healthcare contract research/manufacturing. The Firm typically seeks to commit $50 to $300 million per investment in profitable businesses with at least $10 million of EBITDA. Funds are generally used to support buyouts, recapitalizations, growth financings, consolidations, and divestitures. The Firm avoids investing in companies reliant on high levels of technology. Arsenal Capital Partners was formed in 2000 and is headquartered in New York City.

DEAL STATS #
Overall 39 of 57
Sector (Life Science) 4 of 6
Type (Buyout (LBO, MBO, MBI)) 17 of 19
State (California) 4 of 4
Country (United States) 38 of 50
Year (2019) 1 of 6
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-11-07 Elite Comfort Solutions

Newnan, Georgia, United States

Elite Comfort Solutions, Inc. is a provider of specialty foam. Elite Comfort Solutions has a national network of 16 facilities throughout the U.S. Elite Comfort Solution is based in Newnan, Georgia.

Sell $1.3B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-05-06 Hopebridge

Kokomo, Indiana, United States

Hopebridge provides personalized, comprehensive outpatient Applied Behavior Analysis (ABA), occupational, speech, and feeding therapies for children with an autism spectrum disorder or affected by other behavioral, physical, social, communication, and sensory challenges.

Buy -
Mergr

Product

Company

Legal